Arixtra (fondaparinux sodium), the first in a new class of SYNTHETIC antithrombotics

March 2002

Organon is now launching Arixtra (fondaparinux sodium), the first in a new class of SYNTHETIC antithrombotics.

It's even smaller than the low-molecular weight heparins.

This smaller size allows it to bind more selectively to factor Xa to inhibit thrombin formation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote